Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

72.42
Delayed Data
As of Dec 02
 -0.42 / -0.58%
Today’s Change
71.39
Today|||52-Week Range
105.57
-28.43%
Year-to-Date
5 Dividend Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: Gilead Sciences, Celgene, Express Scripts
Dec 01 / TheStreet.com - Paid Partner Content
3 Reasons Why Incyte Corporation Stock Could Soar in 2017
Dec 03 / MotleyFool.com - Paid Partner Content
5 Things Gilead Sciences' CEO Just Said That You Need to Know
Nov 30 / MotleyFool.com - Paid Partner Content
Forget Pfizer: Here Are 3 Better Dividend Stocks
Dec 02 / MotleyFool.com - Paid Partner Content
17 Questions With Gaspare Civiero of the Value Investor
Nov 30 / GuruFocus News - Paid Partner Content
'Yuge' Sector Rotation Will Continue
Dec 01 / TheStreet.com - Paid Partner Content
Gilead Is a Strong Contrarian 'Buy'
Nov 29 / GuruFocus News - Paid Partner Content
Gilead Sciences, Inc.'s $10 Billion Mistake
Dec 01 / MotleyFool.com - Paid Partner Content
Visualizing Financial Trends With Interactive Charts, Other Topics
Nov 29 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close72.84
Today’s open73.04
Day’s range72.16 - 73.60
Volume9,227,901
Average volume (3 months)9,907,459
Market cap$95.4B
Dividend yield2.60%
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-9.31%
Earnings growth (next 5 years)-4.00%
Revenue growth (last year)+28.71%
P/E ratio6.7
Price/Sales4.80
Price/Book5.56

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+1.62+1.14%
BIIBBiogen+1.41+0.48%
ILMNIllumina Inc+0.18+0.14%
TECHBio-Techne Corp-0.47-0.44%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$2.60
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs